Full Event Guide

Front page

Having trouble downloading?
Let us know and we’ll email it to you instead

Top Reasons to Join:

 

  • Examine how linker stability plays a role in accurate payload release to reduce off-target toxicities and increase targeted delivery with Genentech & Seagen
  • Evaluate the optimal conjugation technology for your ADC design to create an ADC with a homogenous DAR that elicits improved efficacy and developability with Tubulis
  • Address linker design challenges to ensure accurate activation and to encompass clinically relevant linker characteristics into your early-stage development with Iksuda Therapeutics
  • Compare and contrast traditional and novel linker and conjugation technologies to expand your chemistry toolkit and rethink ADC design with Bolt Biotherapeutics & Genequantum
  • Delve into site-specific conjugation technologies to evaluate how the type of site specification conjugation impacts the choice of payload, linker, antibody and target, as well as manufacturing processes with Bristol Myers Squibb
DOWNLOAD HERE
SECURE YOUR PLACE
PARTNER WITH US